Stonepine Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,914,938
| Closed | -$19.2M | – | 37 |
|
|
2021
Q3 | $19.2M | Buy |
3,914,938
+1,220,643
| +45% | +$5.93M | 8.75% | 3 |
|
|
2021
Q2 | $14.2M | Sell |
2,694,295
-723,984
| -21% | -$3.75M | 7.44% | 4 |
|
|
2021
Q1 | $16.4M | Buy |
3,418,279
+2,609,848
| +323% | +$13.6M | 8.86% | 2 |
|
|
2020
Q4 | $3.5M | Buy |
808,431
+150,964
| +23% | +$646K | 2.68% | 11 |
|
|
2020
Q3 | $2.71M | Sell |
657,467
-100,237
| -13% | -$388K | 2.82% | 10 |
|
|
2020
Q2 | $1.94M | Sell |
757,704
-405,172
| -35% | -$1.19M | 3.76% | 10 |
|
|
2020
Q1 | $3.36M | Sell |
1,162,876
-1,078,363
| -48% | -$4.83M | 3.55% | 13 |
|
|
2019
Q4 | $8.49M | Buy |
2,241,239
+1,490,227
| +198% | +$7.13M | 5.92% | 5 |
|
|
2019
Q3 | $3.84M | Sell |
751,012
-672,566
| -47% | -$4.15M | 3.73% | 12 |
|
|
2019
Q2 | $8.83M | Buy |
1,423,578
+439,249
| +45% | +$2.53M | 6.08% | 5 |
|
|
2019
Q1 | $7M | Buy |
+984,329
| New | +$8.85M | 4.03% | 8 |
|